Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

Edward M Messing; Judith Manola; George Wilding; Kathleen Propert; Jonathan Fleischmann; E David Crawford; J Edson Pontes; Richard Hahn; Donald Trump; Eastern Cooperative Oncology Group/Intergroup trial

doi:10.1200/JCO.2003.02.005

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

Identifier:nobleid.org/w1/20260515/150F1ABC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/150F1ABC.svg?ark=w1%2F20260515%2F150F1ABC)](https://nobleid.org/work/w1/20260515/150F1ABC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Eastern Cooperative Oncology Group/Intergroup trial

Claim authorship of this work

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

Identifier:nobleid.org/w1/20260515/150F1ABC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/150F1ABC.svg?ark=w1%2F20260515%2F150F1ABC)](https://nobleid.org/work/w1/20260515/150F1ABC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Eastern Cooperative Oncology Group/Intergroup trial

Claim authorship of this work